Clinical Trials Logo
  1. Home
  2. Hypercholesteremia
  3. NCT00239330

Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy

Hypercholesteremia Clinical Trial

Official title:
An Open-label, Randomised, Multi-centre, Phase IIIb, Parallel Group Study to Compare the Efficacy and Safety of Rosuvastatin and Atorvastatin in Subjects With Type IIa and IIb Hypercholesterolaemia

Clinical Trial Summary

The primary objective of the study is to compare the efficacy of rosuvastatin 10 mg with atorvastatin 10 mg by assessment of the percentage of subjects who reach EAS LDL-C target goals after 12 weeks of therapy.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00239330
Study type Interventional
Source AstraZeneca
Contact
Status Completed
Phase Phase 3
Start date June 2003
Completion date February 2005
View Details
See also
  Status Clinical Trial Phase
Completed NCT05164185 - The Effect of Remote Ischemic Conditioning in Patients With Hypercholesterolemia N/A
Completed NCT00329160 - Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease Phase 4
Completed NCT02634151 - A 12-Week, Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity Statins Phase 2
Completed NCT02587416 - Effect of Gemcabene on the Pharmacokinetics of Atorvastatin in Healthy Volunteers Phase 1
Completed NCT00153738 - Phytosterol Supplementation and Cardiovascular Risk N/A
Completed NCT02722408 - Efficacy and Safety of Gemcabene in Patients With Homozygous Familial Hypercholesterolemia on Stable, Lipid-Lowering Therapy (COBALT-1) Phase 2
Recruiting NCT01890889 - Study of Changes in Total Cholesterol Levels as a Function of Consuming a Supplement Designed to Improve Cardiovascular Health N/A
Completed NCT00376584 - Effect of an Investigational Compound on Tolerability of Extended Release Niacin (0524A-023)(COMPLETED) Phase 3
Completed NCT01477944 - Pattern of Statins Use in Catalonia N/A
Completed NCT00688454 - C-Control: Efficacy and Safety of Therapy With Rosuvastatin in Statin-Naive and in Statin-Switched Patients N/A
Completed NCT00347217 - Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular Event Phase 4
Completed NCT01354327 - Effects of Limicol on LDL-cholesterol N/A
Completed NCT03634436 - The PK/PD Study of A Single Subcutaneous Injection of SHR-1209 in Healthy Subjects Phase 1
Completed NCT00225589 - A Study Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin 40 mg (METEOR) Phase 3
Completed NCT02850224 - Pediatric Preventative Health Screenings - Obesity and Family-Centered Outcomes N/A
Completed NCT00408382 - Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary Plaque Phase 4